Literature DB >> 6972264

Thy and Ly markers on lymphocytes initiating tumor rejection.

M Nelson, D S Nelson, I F McKenzie, R V Blanden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6972264     DOI： 10.1016/0008-8749(81)90245-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  8 in total

1.  T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo.

Authors:  C M Henningsson; S Selvaraj; G D MacLean; M R Suresh; A A Noujaim; B M Longenecker
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Concomitant treatment of MBT-2 bladder tumour by tumour necrosis factor alpha and interferon alpha in conjunction with delayed type hypersensitivity immunotherapy.

Authors:  S A Kadhim; J L Chin
Journal:  Urol Res       Date:  1991

3.  An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

Authors:  P K Lala; I F McKenzie
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

4.  The Lyt phenotype of the T cells responsible for in vivo tumor rejection in syngeneic mice.

Authors:  H Ozawa; T Iwaguchi; T Kataoka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Association of the lymphoproliferative disease inducer gene Arp with autoimmunity and resistance to tumour growth.

Authors:  A Matossian-Rogers
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

6.  Vitamin A and tumor immunity.

Authors:  Y Tomita; K Himeno; K Nomoto; H Endo; T Hirohata
Journal:  Experientia       Date:  1985-01-15

Review 7.  Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy.

Authors:  G Forni; H Fujiwara; F Martino; T Hamaoka; C Jemma; P Caretto; M Giovarelli
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

8.  In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets.

Authors:  S Peppoloni; B J Mathieson; R B Herberman; R W Overton; E Gorelik
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.